Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Verify the report on the official BV website with ID " MIC-ASI236791 "
Liang J, Ran Y, Hu C, Zhou J, Ye L, Su W, et al
The powder may be mixed with an amino acid mixture, dissolved in water or added to other foods and beverages.
Freezing can cause the preservative to separate from the water and may cause microscopic cracks in the glass vial